PEOPLE - AngioDynamics makes appointment:
This article was originally published in Clinica
Vincent Bucci, president and founder of research and consultancy services company Health Policy Associates, has been elected as chairman of the board of AngioDynamics. He succeeds Paul Echenberg, who will remain on the board. Mr Bucci, who has been on the Queensbury, New York company's board since January, was chairman of RITA Medical Systems (now part of AngioDynamics) since 2003, having joined the firm in 1994. Mr Bucci has 26 years experience in management, regulatory affairs and consulting and is considered to have particular expertise in the oncology and interventional businesses.
You may also be interested in...
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.